comparemela.com

Page 7 - David Wainer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA s OK Isn t Always a Happy Day for Biotech Investors | Mint #AskBetterQuestions

Recent approvals of drugs, such as Biogen’s Leqembi, have left investors unimpressed

David wainerPaul matteisEisai leqembiReata pharmaceuticalsDrug administrationBiomarin pharmaceuticalSarepta therapeutic elevidysUs fda

Obesity Drugs Won t Starve These Other Potential Blockbusters

Stocks of developers of fatty liver treatments had been on a tear until some Eli Lilly results spooked investors

Maddie mcgarveyDavid wainerEli lillyDow jones company incWall streetAll rights

It s Time for Revenge Surgeries

Seniors are finally coming back for medical procedures, hobbling insurance giants

David wainerDow jones company incAll rights

As Washington Clamps Down on Big Pharma, Small Is Beautiful Again

Large drug companies need innovation to deal with drug-pricing law. That is a boon to smaller biotech firms.

David wainerMatt rourke associatedDow jones company incAll rightsBiotechnology servicesHealthcare life sciencesRegulation government policyCorporate industrial newsHealthcare policyPolitical general newsPolitics international relationsDomestic politicsSciences humanitiesContent typesFactiva filtersC ampe industry news filter

Vaccine Fatigue Can Give Your Portfolio a Booster

Investors have gotten too bearish on Covid-19 vaccine-makers

David wainerDow jones company incJohn locher associatedAll rightsBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsPolitical general newsRespiratory tract diseasesMedical conditionsOutbreaks epidemicsNovel coronavirusesInfectious diseasesMedical treatments proceduresWsj pro comBiontech se

vimarsana © 2020. All Rights Reserved.